Overview
Coronavirus immunity refers to the protection against coronavirus infection or disease conferred by the immune system, whether acquired through natural infection, vaccination or passive transfer of antibodies. It involves humoral responses, notably neutralising antibodies directed against viral antigens such as the spike protein, and cellular responses, together with innate mechanisms including interferon signalling that shape the early course of infection. For SARS-CoV-2, immunity determines susceptibility to reinfection, the severity of disease and the population-level dynamics of transmission. Research relevant to this topic examines the use of immune modulators such as interferon-gamma, dietary approaches such as plant mannose-binding lectins intended to reduce infection risk, and the concept of herd immunity and the conditions under which it might limit spread. The durability and breadth of immunity are influenced by the molecular evolution of the virus, documented through spike-gene sequence analysis and lineage comparison, which can affect how well prior responses recognise new variants. Host factors and viral pathogenesis, including how affected cells and cytokine responses are regulated, further modulate protection. Understanding coronavirus immunity is therefore central to vaccine design, to interpreting the protection afforded by prior exposure, and to anticipating how immune escape by evolving variants may shape future risk.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
SARS-Corona Virus-2 Origin and Treatment, From Coffee to Coffee: A Double-Edged Sword
Use of Immune Modulator Interferon-Gamma to Support Combating COVID-19 Pandemic
Reducing COVID-19 Risk through Dietary Supplementation of Plant Mannose Binding Lectins
Cell Therapy as an Alternative approach for COVID-19 Infection Consequences: A Non-Systematic Review
Animals in the COVID-19 Era: Between Being a source, Victims, or Maybe our Hope to Overcome it!
Perceived Effect of Knowledge Level and Socio-Demographics on COVID-19 Risk Exposure: the Africa Experience
Pyrexia And Liver Injury After A Second SARS-CoV-2 Vaccination: Macrophage Activation Manifested In Liver
Exponential Parsimony to Generate Herd Immunity Against SARS- CoV2 Cybernetically Restricting Doxastic and Desiderative Logics
Analysis of Risk of Death due to COVID-19 in Cameroon
Features of the Emergence and Re-Emergence of Infectious Diseases, Geopolitics and Gain-of-Function Research
Marginal SARS-CoV-2 Spike Protein Increases Interferon and Balances Cytokine Gene Expression
How this research is being cited
The 12 articles above have been cited 26 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2024 · German Journal of Pharmaceuticals and Biomaterials
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · Revista Brasileira de Farmacognosia
-
Satadal Das et al. · 2023 · International Journal of Applied Biology
-
2023 · Frontiers in Medicine
-
2023 · Frontiers in Medicine
-
2022 · International Journal of Clinical Virology
-
2022 · International Journal of Clinical Virology
A sample of recent works citing this journal's research on Coronavirus Immunity, linking to each citing work.